MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) -- Elucent Medical (“Elucent”), a leading innovator in the field of guided surgical technologies, announced today that the U.S. Food and Drug Administration ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System. The solution enables real-time localisation ...
MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ ...
Elucent Medical is a leading innovator in the field of guided surgical technologies, dedicated to improving patient outcomes through precision and accuracy. The company's flagship technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback